comparemela.com

Page 4 - Daniel Clair News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study backs LimFlow system for treating limb-threatening ischemia

LimFlow said new study results demonstrated statistically significant survival with its chronic limb-threatening ischemia (CLTI) treatment.

Daniel clairMehdi shishehborDan roseUniversity hospitalsVascular instituteParis based limflowNew england journalHarrington heartVanderbilt university medical center sectionLimflow system

LimFlow System s PROMISE II Pivotal Trial Results Published

March 30, 2023—LimFlow SA, a developer of minimally invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), announced

United statesVanderbilt universityMehdi shishehborDaniel clairLas vegasUniversity hospitalsVascular instituteFoundation onNew england journalLate breaking clinical trialsCoprincipal investigatorsHarrington heartVascular surgeryVanderbilt university medical center sectionSurgical sciencesLimflow sa

Global Thought Leaders Continue to Join the VESTECK Advisory Team

/PRNewswire/ VESTECK, Inc. is proud to announce that another global Endovascular thought leader, Professor Michel Reijnen has agreed to join the VESTECK.

United statesJoe raffertyMichel reijnenUniversity of twenteVenkatesh ramaiah md honor healthSource vesteck incVesteck incWilliam gray md main line healthPrnewswire vesteck incProfessor michel reijnenProfessor reijnenVascular surgeonRijnstate hospitalScientific advisoryAdvisory boardSean lyden

2023 International Symposium on Endovascular Therapy (ISET) strengthened by partnerships with leading organizations SIR, SVM, SVS

Malvern, Pa. (PRWEB) November 17, 2022 HMP Global’s 2023 International Symposium on Endovascular Therapy (ISET) is strengthening its position as the

United statesMiami beachUniversity of south floridaSouth miamiHoward university hospitalDistrict of columbiaFlorida international universityJessica simonsKakra hughesWilliam grayKenia lynnDaniel clairBrian schiroShripal gandhiAlex powellBarryt katzen

LimFlow System s 6-Month Outcomes Presented From the PROMISE II US Pivotal Trial

November 4, 2022—Six-month results from the PROMISE II United States pivotal trial of transcatheter arterialization of the deep veins with the L

United statesDaniel clairLas vegasFoundation onLimflow incLate breaking clinical trialsPromise iiTranscatheter arterializationDeep veinsAmputation free survivalChronic limb threatening ischemiaLate breaking clinical trialsLimb salvage

vimarsana © 2020. All Rights Reserved.